16-May-25 |
Buy |
Blathnaid Bergin |
404.27p | 6,145 |
£24,842.39 |
09-May-25 |
Buy |
Marie-Anne Aymerich |
405.10p | 21,300 |
£86,286.30 |
02-May-25 |
Buy |
Asmita Dubey |
401.00p | 15,424 |
£61,850.24 |
09-May-25 |
Buy |
Marie-Anne Aymerich |
405.10p | 21,300 |
£86,286.30 |
02-May-25 |
Buy |
Asmita Dubey |
401.00p | 15,424 |
£61,850.24 |
16-May-25 |
Buy |
Blathnaid Bergin |
404.27p | 6,145 |
£24,842.39 |
Brian McNamara |
533,290 |
£2,195,022 |
Manvinder Singh (Vindi) Banga |
258,000 |
£1,061,928 |
Dave Lewis |
94,627 |
£389,485 |
Dawn Allen |
83,974 |
£345,637 |
Marie-Anne Aymerich |
49,184 |
£202,441 |
Alan Stewart |
33,923 |
£139,627 |
Asmita Dubey |
15,424 |
£63,485 |
Tracy Jayne Clarke |
12,504 |
£51,466 |
Blathnaid Bergin |
6,145 |
£25,293 |
Pfizer Inc. |
661,709,764 |
£2,723,597,389 |
Berkeley Square Pension Trustee Company Limited |
602,094,214 |
£2,478,219,785 |
Wellington Management Group LLP |
499,089,557 |
£2,054,252,617 |
BlackRock, Inc. |
453,808,467 |
£1,867,875,650 |
|
Final |
Interim |
Ex-Div |
24-Apr-25 |
15-Aug-24 |
Paid |
05-Jun-25 |
19-Sep-24 |
Amount |
4.60p |
2.00p |
15:37 |
5,302,473 @ 412.60p |
15:37 |
5,302,473 @ 412.60p |
16:35 |
2,979 @ 411.60p |
16:35 |
39,544 @ 411.60p |
16:29 |
636 @ 411.00p |
CEO |
Brian McNamara |
CFO |
Dawn Allen |
Top of Page
You are here:
research